会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • TREATMENT OF CONGESTIVE HEART FAILURE
    • 治疗心绞痛失败
    • WO2003039578A1
    • 2003-05-15
    • PCT/SE2002/002048
    • 2002-11-08
    • SAHLTECH I GÖTEBORG ABISAKSSON, OlleISGAARD, JörgenJOHANNSSON, Gudmundur
    • ISAKSSON, OlleISGAARD, JörgenJOHANNSSON, Gudmundur
    • A61K38/27
    • A61K38/27A61K2300/00
    • The use of at least one first substance related to the growth hormone (GH) axis, and of at least one second substance, wherein said second substance upon administration to a patient leads to increased beta adrenergic receptor blockade, for the production of a pharmaceutical composition for the treatment of congestive heart failure (CHF) is disclosed. The use of said at least one first or second substance, respectively, for the production of a pharmaceutical composition for the treatment of congestive heart failure (CHF), intended for administration in combination with a pharmaceutical composition comprising said at least one second or first substance, respectively, is also disclosed. Also a method for treatment of congestive heart failure (CHF), wherein a pharmaceutically active amount of said at least one first substance is administered to a patient in combination with the administration to a patient of a pharmaceutically active amount of said at least one second substance is disclosed.
    • 使用与生长激素(GH)轴相关的至少一种第一物质和至少一种第二物质,其中所述第二物质在给予患者时导致增加的β-肾上腺素能受体阻断用于制备药物组合物 用于治疗充血性心力衰竭(CHF)。 分别使用所述至少一种第一或第二物质来生产用于治疗充血性心力衰竭(CHF)的药物组合物,其用于与包含所述至少一种第二或第一物质 ,也分别公开。 还有一种治疗充血性心力衰竭(CHF)的方法,其中将药物活性量的所述至少一种第一物质与药物活性量的所述至少一种第二物质一起施用给患者 被披露。